D. E. Shaw & Co., Inc. Semler Scientific, Inc. Transaction History

D. E. Shaw & Co., Inc.

$122 Billion
Q4 2024

A detailed history of D. E. Shaw & Co., Inc. transactions in Semler Scientific, Inc. stock. As of the latest transaction made, D. E. Shaw & Co., Inc. holds 8,132 shares of SMLR stock, worth $269,982. This represents 0.0% of its overall portfolio holdings.

Number of Shares

8,132

Holding current value

$269,982

% of portfolio

0.0%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$22.48 - $74.73 $182,807 - $607,704	8,132 New	8,132 $439,000
Q2 2024 Aug 14, 2024	SELL	$21.03 - $40.57 $1.33 Million - $2.57 Million	-63,228 Reduced 84.45%	11,639 $400,000
Q1 2024 May 15, 2024	SELL	$28.42 - $51.54 $1.44 Million - $2.61 Million	-50,720 Reduced 40.39%	74,867 $2.19 Million
Q4 2023 Feb 14, 2024	BUY	$25.66 - $46.29 $353,440 - $637,598	13,774 Added 12.32%	125,587 $5.56 Million
Q3 2023 Nov 14, 2023	BUY	$23.15 - $28.54 $169,319 - $208,741	7,314 Added 7.0%	111,813 $2.84 Million
Q2 2023 Aug 14, 2023	BUY	$22.5 - $30.58 $277,357 - $376,959	12,327 Added 13.37%	104,499 $2.74 Million
Q1 2023 May 15, 2023	BUY	$19.28 - $41.74 $589,813 - $1.28 Million	30,592 Added 49.68%	92,172 $2.47 Million
Q4 2022 Feb 14, 2023	BUY	$28.01 - $43.49 $50,249 - $78,021	1,794 Added 3.0%	61,580 $2.03 Million
Q3 2022 Nov 14, 2022	BUY	$27.75 - $45.8 $46,814 - $77,264	1,687 Added 2.9%	59,786 $2.25 Million
Q2 2022 Aug 15, 2022	BUY	$27.86 - $50.32 $656,938 - $1.19 Million	23,580 Added 68.31%	58,099 $1.64 Million
Q1 2022 May 16, 2022	BUY	$42.24 - $93.25 $1.46 Million - $3.22 Million	34,519 New	34,519 $1.71 Million

Others Institutions Holding SMLR

# of Institutions

125

Shares Held

6.41M

Call Options Held

99.6K

Put Options Held

51.6K

View Full List

About Semler Scientific, Inc.

Ticker SMLR
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 6,800,580
Market Cap $226M
Description
Semler Scientific, Inc. provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's va...

More about SMLR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.

Account